| Width: | 250px |
| Tradename: | Decentan Depot, Peratsin Enantaatti, Trilafon, Trilafon Enantato, Trilafon Enantat, Trilifan Retard |
| Routes Of Administration: | Intramuscular injection |
| Class: | Typical antipsychotic |
| Atc Prefix: | N05 |
| Atc Suffix: | AB03 |
| Legal Status: | Rx-only |
| Cas Number: | 17528-28-8 |
| Pubchem: | 62871 |
| Drugbank: | DB14651 |
| Chemspiderid: | 56601 |
| Unii: | Z6RS3DKN8J |
| Kegg: | D08342 |
| Synonyms: | Perphenazine enantate |
| Iupac Name: | 2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl heptanoate |
| C: | 28 |
| H: | 38 |
| Cl: | 1 |
| N: | 3 |
| O: | 2 |
| S: | 1 |
| Smiles: | CCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl |
| Stdinchi: | 1S/C28H38ClN3O2S/c1-2-3-4-5-11-28(33)34-21-20-31-18-16-30(17-19-31)14-8-15-32-24-9-6-7-10-26(24)35-27-13-12-23(29)22-25(27)32/h6-7,9-10,12-13,22H,2-5,8,11,14-21H2,1H3 |
| Stdinchikey: | PWEGQJCIAMJJHC-UHFFFAOYSA-N |
Perphenazine enanthate, sold under the brand name Trilafon Enantat among others, is a typical antipsychotic and a depot antipsychotic ester which is used in the treatment of schizophrenia and has been marketed in Europe.[1] [2] [3] [4] [5] [6] It is formulated in sesame oil and administered by intramuscular injection and acts as a long-lasting prodrug of perphenazine. Perphenazine enanthate is used at a dose of 25 to 200 mg once every 2 weeks by injection, with a time to peak levels of 2 to 3 days and an elimination half-life of 4 to 7 days.